The Cohort for patient-reported Outcomes, Imaging and trial inclusion in Metastatic BRAin disease

Recruiting

• Conditions: Brain metastases; metastatic brain disease; 10029211

• Registration Number: NL-OMON52435
• Lead Sponsor: niversitair Medisch Centrum Utrecht

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 2000

Inclusion Criteria

- Age >= 18 years;
- Either radiographic and/or histologic proof of metastatic brain disease, or
eligible for prophylactic cranial irradiation;
- Referred to the Department of Radiotherapy for cranial irradiation.

Exclusion Criteria

- Mental disorder or cognitive dysfunction that hinder the patient*s ability to
understand the informed consent procedure and/or study details;
- Patients with severe psychiatric disorders;
- Inability to understand the Dutch language.

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Clinical parameters (co-morbidity, oncological history, symptoms, imaging,<br /><br>technical and treatment data), clinical endpoints (toxicity, reintervention and<br /><br>survival) and patient reported outcomes.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Not applicable.</p><br>